Joana Torres

Professora Auxiliar

Faculty of Medicine, University of Lisbon

Portugal

Research Interests

Explore related searches

Professors in Portugal

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Joana Torres is an Auxiliar Professor at the Faculdade de Medicina, Universidade de Lisboa, Portugal. Her research focuses on inflammatory bowel disease (IBD), with recent articles exploring management during pregnancy, quality of life improvements in ulcerative colitis, and the impact of maternal IBD status on offspring. She is actively involved in the development of consensus statements and clinical guidelines to enhance care for patients with chronic digestive diseases.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (6)

Edward Loftus

Professor of Medicine

Mayo Clinic Rochester

UNITED STATES

View details

Neilanjan Nandi

Associate Professor of Clinical Medicine

University of Pennsylvania

UNITED STATES

View details

Raymond Cross

University of Maryland School of Medicine

UNITED STATES

View details

Linéa Bonfils

Aalborg University

DENMARK

View details

Henrik Albaek Jacobsen

Aalborg University

DENMARK

View details

Kristine Højgaard Allin

Aalborg University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joana Torres

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease

Transition From Youth to Adulthood: UEG 2024 Roundtable on Navigating Chronic Digestive and Liver Disease Care

Symptom Resolution and Meaningful Improvement in Quality of Life With Risankizumab in Patients With Ulcerative Colitis: Post Hoc Analysis of the Randomized INSPIRE and COMMAND Studies

Ultrasonido intestinal en la Enfermedad Inflamatoria Intestinal: ¿cuándo utilizarlo y cómo aplicarlo eficazmente?

A Simple Endoscopic Score for Crohn's Disease (SES‐CD) ≥ 7 Predicts Disease Progression

Alterations in mucosa branched N-glycans lead to dysbiosis and downregulation of ILC3: a key driver of intestinal inflammation

Prediction and Prevention of Inflammatory Bowel Disease

The Future of Inflammatory Bowel Disease Care

Body Mass Index Did Not Affect Efficacy and Safety of Etrasimod: A Post Hoc Analysis of the ELEVATE Ulcerative Colitis Clinical Program

Impact of prenatal and postnatal maternal IBD status on offspring’s risk of IBD: a population-based cohort study

Collaborators (6)

Edward Loftus

Neilanjan Nandi

Raymond Cross

Linéa Bonfils

Henrik Albaek Jacobsen

Kristine Højgaard Allin

Make your next move.